Uncommon Cents Investing LLC decreased its position in shares of CVS Health Co. (NYSE:CVS – Get Rating) by 0.5% during the second quarter, HoldingsChannel reports. The institutional investor owned 27,510 shares of the pharmacy operator’s stock after selling 145 shares during the period. Uncommon Cents Investing LLC’s holdings in CVS Health were worth $2,549,000 as of its most recent SEC filing.
Other institutional investors have also recently made changes to their positions in the company. Kayne Anderson Rudnick Investment Management LLC grew its holdings in shares of CVS Health by 1.8% in the fourth quarter. Kayne Anderson Rudnick Investment Management LLC now owns 83,024 shares of the pharmacy operator’s stock worth $8,565,000 after acquiring an additional 1,450 shares during the period. GSA Capital Partners LLP purchased a new position in CVS Health during the fourth quarter valued at $825,000. Clearstead Advisors LLC lifted its position in CVS Health by 9.7% during the fourth quarter. Clearstead Advisors LLC now owns 12,717 shares of the pharmacy operator’s stock valued at $1,312,000 after purchasing an additional 1,121 shares in the last quarter. Summit Global Investments lifted its position in CVS Health by 5.7% during the fourth quarter. Summit Global Investments now owns 13,917 shares of the pharmacy operator’s stock valued at $1,436,000 after purchasing an additional 751 shares in the last quarter. Finally, Liberty Capital Management Inc. purchased a new position in CVS Health during the fourth quarter valued at $229,000. Hedge funds and other institutional investors own 77.64% of the company’s stock.
CVS Health Price Performance
Shares of NYSE:CVS traded down $1.99 during trading on Friday, reaching $97.84. 166,419 shares of the company’s stock traded hands, compared to its average volume of 4,398,985. CVS Health Co. has a fifty-two week low of $81.78 and a fifty-two week high of $111.25. The company has a quick ratio of 0.65, a current ratio of 0.91 and a debt-to-equity ratio of 0.67. The firm has a market cap of $128.45 billion, a PE ratio of 15.91, a P/E/G ratio of 1.52 and a beta of 0.73. The company has a 50-day simple moving average of $100.14 and a 200-day simple moving average of $99.28.
CVS Health Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Tuesday, November 1st. Stockholders of record on Friday, October 21st will be issued a dividend of $0.55 per share. The ex-dividend date of this dividend is Thursday, October 20th. This represents a $2.20 dividend on an annualized basis and a dividend yield of 2.25%. CVS Health’s dividend payout ratio is currently 35.77%.
Analyst Ratings Changes
Several equities analysts have recently commented on the company. Tigress Financial boosted their price objective on CVS Health from $125.00 to $130.00 in a research report on Wednesday, August 17th. Loop Capital began coverage on CVS Health in a research report on Thursday, June 16th. They issued a “buy” rating and a $120.00 price objective on the stock. Sanford C. Bernstein downgraded CVS Health from an “outperform” rating to a “market perform” rating and decreased their target price for the stock from $122.00 to $112.00 in a research report on Thursday, May 26th. UBS Group boosted their target price on CVS Health from $118.00 to $127.00 and gave the stock a “buy” rating in a research report on Thursday, August 4th. Finally, Evercore ISI boosted their target price on CVS Health from $120.00 to $125.00 and gave the stock an “outperform” rating in a research report on Wednesday, September 7th. Four investment analysts have rated the stock with a hold rating, nineteen have issued a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $117.59.
Insider Activity at CVS Health
In other news, EVP Alan Lotvin sold 22,541 shares of CVS Health stock in a transaction on Thursday, August 4th. The shares were sold at an average price of $104.00, for a total transaction of $2,344,264.00. Following the completion of the sale, the executive vice president now directly owns 109,183 shares of the company’s stock, valued at approximately $11,355,032. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. In other news, EVP Thomas M. Moriarty sold 138,654 shares of the business’s stock in a transaction dated Tuesday, June 28th. The shares were sold at an average price of $95.00, for a total transaction of $13,172,130.00. Following the transaction, the executive vice president now directly owns 626,273 shares in the company, valued at $59,495,935. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, EVP Alan Lotvin sold 22,541 shares of the company’s stock in a transaction dated Thursday, August 4th. The stock was sold at an average price of $104.00, for a total transaction of $2,344,264.00. Following the transaction, the executive vice president now owns 109,183 shares in the company, valued at $11,355,032. The disclosure for this sale can be found here. 0.69% of the stock is owned by insiders.
CVS Health Company Profile
CVS Health Corporation provides health services in the United States. The company's Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates.
- Get a free copy of the StockNews.com research report on CVS Health (CVS)
- Why Does Tesla Stock Remain Resilient?
- Is Costco’s Post-Earnings Price Weakness A Good Time To Buy?
- Are Layoffs At A Small-Cap Tech A Bellwether For Housing Stocks?
- Will Crowdstrike Get A Boost From Increased EPS Guidance?
- 2 Semiconductor Stocks To Watch For Reversals
Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.